GeneDx Holdings Corp.
WGS
21 insider filings · Latest: May 7, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | Mar 26 10:36 PM | Kevin Feeley | Proposed Sale | 8,746 | $95.61 | $836.2K | — | View → |
| Mar 26, 2025 | Mar 26 10:34 PM | Katherine Stueland | Proposed Sale | 46,551 | $95.62 | $4.5M | — | View → |
| Mar 17, 2025 | Mar 17 10:46 PM | Kevin Feeley | Proposed Sale | 3,749 | $96.72 | $362.6K | — | View → |
| Mar 17, 2025 | Mar 17 10:44 PM | Katherine Stueland | Proposed Sale | 10,559 | $96.70 | $1.0M | — | View → |
| Mar 13, 2025 | Mar 13 11:04 PM | Kevin Feeley | Proposed Sale | 402 | $90.05 | $36.2K | — | View → |
| Mar 13, 2025 | Mar 13 11:03 PM | Katherine Stueland | Proposed Sale | 1,078 | $89.42 | $96.4K | — | View → |
| Mar 10, 2025 | Mar 10 11:44 PM | Kevin Feeley | Proposed Sale | 922 | $94.69 | $87.3K | — | View → |
| Mar 10, 2025 | Mar 10 11:43 PM | Katherine Stueland | Proposed Sale | 2,731 | $94.73 | $258.7K | — | View → |
| Mar 3, 2025 | Mar 3 11:59 PM | Kevin Feeley | Proposed Sale | 261 | $103.83 | $27.1K | — | View → |
| Feb 24, 2025 | Feb 25 1:00 AM | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | Proposed Sale | 747,138 | $95.83 | $71.6M | — | View → |
| Jan 30, 2025 | Jan 31 1:02 AM | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | Proposed Sale | 2,692,246 | $77.86 | $209.6M | — | View → |
| Jan 29, 2025 | Jan 30 2:06 AM | Kevin Feeley | Proposed Sale | 275 | $78.55 | $21.6K | — | View → |
| Jan 29, 2025 | Jan 30 2:04 AM | Katherine Stueland | Proposed Sale | 1,657 | $78.46 | $130.0K | — | View → |
| Jan 7, 2025 | Jan 7 10:02 PM | Feeley Kevin | Proposed Sale | 35,506 | $94.07 | $3.3M | — | View → |
| Jan 7, 2025 | Jan 7 9:44 PM | Stueland Katherine | Proposed Sale | 51,420 | $93.93 | $4.8M | — | View → |
| Jan 2, 2025 | Jan 2 10:03 PM | Feeley Kevin | Proposed Sale | 1,430 | $75.52 | $108.0K | — | View → |
| Jan 2, 2025 | Jan 2 9:31 PM | Stueland Katherine | Proposed Sale | 18,006 | $77.75 | $1.4M | — | View → |
| Dec 16, 2024 | Dec 17 1:41 AM | Kevin Feeley | Proposed Sale | 3,728 | $76.75 | $286.1K | — | View → |
| Dec 16, 2024 | Dec 17 1:40 AM | Katherine Stueland | Proposed Sale | 10,501 | $76.75 | $806.0K | — | View → |
| Dec 9, 2024 | Dec 10 1:06 AM | Kevin Feeley | Proposed Sale | 1,137 | $76.37 | $86.8K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | May 12 12:43 AM | Casdin Capital, LLCDirector, 10% Owner | Purchase | 50,000 | — | 850,000(I) | View → |
| May 8, 2026 | May 12 12:43 AM | Casdin Capital, LLCDirector, 10% Owner | Purchase | 300,000 | — | 800,000(I) | View → |
| May 7, 2026 | May 12 12:43 AM | Casdin Capital, LLCDirector, 10% Owner | Purchase | 500,000 | — | 500,000(I) | View → |
| Apr 29, 2026 | May 1 8:28 PM | Katherine StuelandDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 3,874 | — | 0(D) | View → |
| Apr 29, 2026 | May 1 8:24 PM | Kevin FeeleyCHIEF FINANCIAL OFFICER | Option Exercise | 754 | — | 0(D) | View → |
| Mar 26, 2026 | Mar 30 9:38 PM | Kevin FeeleyCHIEF FINANCIAL OFFICER | Option Exercise | 16,250 | — | 32,500(D) | View → |
| Mar 26, 2026 | Mar 30 9:30 PM | Katherine StuelandDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 80,000 | — | 160,000(D) | View → |
| Mar 16, 2026 | Mar 17 10:40 PM | Katherine StuelandDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 18,750 | — | 75,000(D) | View → |
| Mar 15, 2026 | Mar 17 10:40 PM | Katherine StuelandDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 11,921 | — | 35,763(D) | View → |
| Mar 16, 2026 | Mar 17 10:39 PM | Kevin FeeleyCHIEF FINANCIAL OFFICER | Option Exercise | 7,197 | — | 28,787(D) | View → |
| Mar 15, 2026 | Mar 17 10:39 PM | Kevin FeeleyCHIEF FINANCIAL OFFICER | Option Exercise | 3,815 | — | 11,446(D) | View → |
| Mar 9, 2026 | Mar 11 8:28 PM | Kevin FeeleyCHIEF FINANCIAL OFFICER | Option Exercise | 2,462 | — | 7,387(D) | View → |
| Mar 9, 2026 | Mar 11 8:26 PM | Katherine StuelandDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 6,546 | — | 19,640(D) | View → |
| Mar 3, 2026 | Mar 5 10:50 PM | Bryan DechairoChief Operating Officer | Grant/Award | 10,430 | — | 10,430(D) | View → |
| Mar 3, 2026 | Mar 5 10:49 PM | Kevin FeeleyCHIEF FINANCIAL OFFICER | Grant/Award | 10,865 | — | 10,865(D) | View → |
| Mar 3, 2026 | Mar 5 10:46 PM | Katherine StuelandDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 40,418 | — | 40,418(D) | View → |
| Mar 1, 2026 | Mar 3 9:38 PM | Kevin FeeleyCHIEF FINANCIAL OFFICER | Option Exercise | 718 | — | 1,434(D) | View → |
| Feb 1, 2026 | Feb 4 12:30 AM | Bryan DechairoChief Operating Officer | Option Exercise | 9,374 | — | 28,123(D) | View → |
| Jan 29, 2026 | Feb 2 9:33 PM | Kevin FeeleyCHIEF FINANCIAL OFFICER | Option Exercise | 754 | — | 754(D) | View → |
| Jan 29, 2026 | Feb 2 9:30 PM | Katherine StuelandDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 3,874 | — | 3,874(D) | View → |